Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and <i>N</i>-Acetylcysteine against Tobramycin-Resistant <i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, and <i>Acinetobacter baumannii</i>

• Egile Nagusiak: Reem E. Alarfaj (Egilea), Manal M. Alkhulaifi (Egilea), Ahmed J. Al-Fahad (Egilea), Shokran Aljihani (Egilea), Alaa Eldeen B. Yassin (Egilea), Majed F. Alghoribi (Egilea), Majed A. Halwani (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2022-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The antibacterial activity and biofilm reduction capability of liposome formulations encapsulating tobramycin (TL), and Tobramycin-<i>N</i>-acetylcysteine (TNL) were tested against tobramycin-resistant strains of <i>E. coli</i>, <i>K. pneumoniae</i> and <i>A...